Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
Abroad (travel likely)RecruitingPHASE1
Conditions
Vaccine-Preventable Diseases · Herpes Zoster
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Eunpyeong-gu, South Korea
Contact: Study coordinator (Jeonghyeon Choi)Bundang CHA General Hospital, Seongnam-si, Gyeonggi-do, South Korea
Contact: Study coordinator (Jonghoon Kim)
Study leads
Jeonghyeon Choi
Principal Investigator
The Catholic University of Korea Eunpyeong St. Mary's Hospital